Hypercalcemia in patients with known malignent disease

Area of Science:

• Endocrinology
• Oncology
• Medical Diagnostics

Background:

• Primary hyperparathyroidism is a condition characterized by excessive parathyroid hormone (iPTH) secretion.
• Co-occurrence of hyperparathyroidism and cancer presents diagnostic challenges.
• Ectopic hormone production by tumors can mimic primary hyperparathyroidism.

Purpose of the Study:

• To investigate the diagnostic utility of neck vein catheterization and serum iPTH measurement in patients with suspected primary hyperparathyroidism.
• To determine the prevalence and implications of coexisting primary hyperparathyroidism in cancer patients.
• To explore the role of elevated iPTH in the superior vena cava in patients with thoracic malignancies.

Main Methods:

• Transfemoral neck vein catheterization and serum iPTH measurement in 82 patients.
• Analysis of iPTH levels in effluent blood from cancer sites in hypercalcemic patients.
• Surgical exploration and pathological examination in select cases.

Main Results:

• Primary hyperparathyroidism was diagnosed preoperatively in 82 patients.
• Twenty-five patients had concurrent cancer without recurrence.
• Ectopic iPTH production was identified in six patients; one patient with breast cancer and liver metastases showed elevated superior vena cava iPTH, later found to have parathyroid adenoma.
• Postmortem analysis confirmed widespread metastases and iPTH in the liver.

Conclusions:

• Neck vein catheterization and analysis of tumor effluent aid in localizing iPTH production.
• Primary hyperparathyroidism frequently coexists with cancer and requires recognition.
• Elevated superior vena cava iPTH can indicate thoracic malignancy or parathyroid pathology.
• Hyperparathyroidism may be an early sign of familial multiple endocrine neoplasia syndromes.